Camurus: Positive Results in POSITANO - Redeye
Bildkälla: Stockfoto

Camurus: Positive Results in POSITANO - Redeye

Redeye comments on the topline data from the phase II study POSITANO, which investigates the effect of CAM2029 in polycystic liver disease.

Redeye comments on the topline data from the phase II study POSITANO, which investigates the effect of CAM2029 in polycystic liver disease.
Börsvärldens nyhetsbrev